Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people.

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic ...

South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates, and they ...

Earlier this year, Health and Human Services Secretary Robert F. Kennedy Jr. pledged that the search for autism's cause—a ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

The UK is facing an "unprecedented wave of super flu," a health chief has warned, as Prime Minister Keir Starmer Friday ...

Europe calls for decisive action to transform how Europe monitors noncommunicable diseases (NCDs). Developed jointly by Joint ...

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...

A study by researchers at the Federal University of São Carlos (UFSCar) in Brazil, in partnership with University College ...

The U.S. Food and Drug Administration has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant ...